1. Hepatotoxicity & Drug-induced Liver Injury Testing Market – Market Overview
1.1 Definitions and Scope
2. Hepatotoxicity & Drug-induced Liver Injury Testing Market – Executive Summary
3. Hepatotoxicity & Drug-induced Liver Injury Testing Market – Landscape
3.1.1 Market Share Analysis – Major Companies
3.1.2 Product Benchmarking – Major Companies
3.1.3 Top 5 Financials Analysis
3.1.4 Patent Analysis – Major Companies
3.1.5 Pricing Analysis
4. Hepatotoxicity & Drug-induced Liver Injury Testing Market – Startup Companies Scenario Premium
4.1 Top Startup Company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Product Portfolio
4.1.4 Venture Capital and Funding Scenario
5. Hepatotoxicity & Drug-induced Liver Injury Testing Market – Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing Business Index
5.3 Successful Venture Profiles
5.4 Customer Analysis – Major Companies
6. Hepatotoxicity & Drug-induced Liver Injury Testing Market – Market Forces
6.1 Market Drivers
6.2 Market Constraints
6.3 Porter’s Five Forces Model
6.3.1 Bargaining Power of Suppliers
6.3.2 Bargaining Power of Customers
6.3.3 Threat of New Entrants
6.3.4 Rivalry Among Existing Players
6.3.5 Threat of Substitutes
7. Hepatotoxicity & Drug-induced Liver Injury Testing Market – Strategic Analysis
7.1 Value Chain Analysis
7.2 Opportunities Analysis
7.3 Suppliers and Distributors Analysis
8. Hepatotoxicity & Drug-induced Liver Injury Testing Market – By Xenobiotics Type (Market Size – $ Million)
8.1 Drugs
8.2 Alcohol
8.3 Food Additives
8.4 Chlorinated Solvents
8.5 Fungal Toxins
8.6 Radioactive Isotopes
8.7 Environmental Toxins
8.8 Others
9. Hepatotoxicity & Drug-induced Liver Injury Testing Market – By Technology Type (Market Size – $ Million)
9.1 ELISA
9.2 Rapid Diagnostic Tests
9.3 Polymerase Chain Reaction (PCR) Tests
9.4 Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
9.5 Imaging Tests (CT, MRI, Ultrasound, etc.)
9.6 Others
10. Hepatotoxicity & Drug-induced Liver Injury Testing Market – By Testing Product (Market Size – $ Million)
10.1 Testing Equipment
10.2 Assay Kits
10.3 Consumables
10.4 Software
10.5 Services
10.6 Others
11. Hepatotoxicity & Drug-induced Liver Injury Testing Market – By End User (Market Size – $ Million)
11.1 Hospitals
11.2 Diagnostic Laboratories
11.3 Blood Banks
11.4 Medical Research Labs
11.5 Pharmaceutical Companies
11.6 Others
12. Hepatotoxicity & Drug-induced Liver Injury Testing Market – By Geography (Market Size – $ Million)
12.1 North America
12.1.1 USA
12.1.2 Canada
12.1.3 Mexico
12.2 South America
12.2.1 Brazil
12.2.2 Argentina
12.2.3 Rest of SA
12.3 Europe
12.3.1 UK
12.3.2 Germany
12.3.3 France
12.3.4 Italy
12.3.5 Netherlands
12.3.6 Spain
12.3.7 Russia
12.3.8 Denmark
12.3.9 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Australia
12.4.3 Japan
12.4.4 South Korea
12.4.5 India
12.4.6 Taiwan
12.4.7 Rest of APAC
13. Hepatotoxicity & Drug-induced Liver Injury Testing Market – Entropy
13.1 New Product Launches
13.2 M&As, Collaborations, JVs, and Partnerships
14. Hepatotoxicity & Drug-induced Liver Injury Testing Market – Industry/Segment Competition Landscape Premium
14.1 Company Benchmarking Matrix – Major Companies
14.2 Market Share at Global Level – Major Companies
14.3 Market Share by Key Region – Major Companies
14.4 Market Share by Key Country – Major Companies
14.5 Market Share by Key Product Type – Major Companies
15. Hepatotoxicity & Drug-induced Liver Injury Testing Market – Key Company List by Country Premium
16. Hepatotoxicity & Drug-induced Liver Injury Testing Market Company Profiles – Product Portfolio, Financials, M&A, and Developments
16.1 Eurofins
16.2 Sigma Aldrich
16.3 Mayo Clinic
16.4 Syngene International Ltd
16.5 Visikol Inc (BICO)
16.6 Cyprotex
16.7 BioIVT
16.8 XenoTech
16.9 Hemogenix Inc
16.10 Hamilton Company
Financials would be provided on a best-efforts basis for private companies
